Wall Street Analysts Predict an 112.56% Upside in Immunocore (IMCR): Here's What You Should Know

Core Viewpoint - Immunocore Holdings PLC (IMCR) shows significant upside potential, with a mean price target of $72.93 indicating an 112.6% increase from its current price of $34.31 [1] Price Target Analysis - The average of 15 short-term price targets ranges from a low of $24 to a high of $100, with a standard deviation of $18.74, indicating variability in analyst estimates [2] - The lowest estimate suggests a decline of 30.1%, while the most optimistic estimate indicates a potential upside of 191.5% [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [7] Earnings Estimates - Analysts have shown increasing optimism about IMCR's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [9] - The Zacks Consensus Estimate for the current year has risen by 4.1% over the past month, with no negative revisions [10] Analyst Behavior - Analysts often set overly optimistic price targets due to business incentives, which can lead to inflated estimates [6] - Despite the skepticism surrounding price targets, a tight clustering of estimates can provide a useful starting point for further research [7][8] Zacks Rank - IMCR holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [11]